All articles

Press Releases Bg

iOnctura expands pipeline and receives development grant from Health Holland and KWF

Press Releases Bg

iOnctura awarded UK’s MHRA innovation passport for entry into innovative licensing and access pathway (ILAP)

Press Releases Bg

iOnctura announces publication of pioneering research describing the unique biological features of roginolisib

Press Releases Bg

iOnctura provides development update on first-in-class semi-allosteric PI3Kδ inhibitor program

Press Releases Bg

iOnctura awarded EUR17.5 million funding from the EIC accelerator for clinical development of novel pancreatic cancer therapy

Press Releases Bg

iOnctura initiates Phase Ib pancreatic cancer trial of next-generation autotaxin inhibitor IOA-289

Press Releases Bg

iOnctura expands Advisory Board

Press Releases Bg

iOnctura to present at ASCO IOA-244 showing highly promising impact on overall survival for patients with metastatic and refractory uveal melanoma

Press Releases Bg

iOnctura to present at ASCO encouraging Phase Ib refractory uveal melanoma data for first semi-allosteric PI3Kδ inhibitor, IOA-244

Press Releases Bg

iOnctura data at AACR demonstrates unique mechanism of action for clinical stage autotaxin inhibitor IOA-289

Press Releases Bg

iOnctura to present preclinical data on its clinical stage autotaxin inhibitor, IOA-289, at AACR

Hero Bg

Looking for media
resources?

iOnctura
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.